b 171 (Mefloquine 250 mg)
Pill imprint b 171 has been identified as Mefloquine hydrochloride 250 mg.
Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. Risk cannot be ruled out during pregnancy. Mefloquine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for b 171 (Mefloquine 250 mg)
- 250 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|54569-5407||A S Medication Solutions LLC (repackager)|
|23490-5858||Palmetto State Pharmaceuticals Inc (repackager)|
|21695-0449||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about mefloquine
- Other brands: Lariam
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...